Risk assessment of cardiovascular diseases among bank employees - A biochemical approach

Occupational Medicine

Volumn 49, Issue 5, 1999, Pages 313-318

  Sarkar, A K ^a   Adak, S K ^a   Bhattacharya, P ^b   Marimuthu, P ^b   Chaudhuri, R N ^b   Banerjee, K K ^b  

^a UNIVERSITY OF CALCUTTA   (India)

^b ALL INDIA INSTITUTE OF HYGIENE AND PUBLIC HEALTH   (India)

Author keywords

Antioxidant defence; Cardiovascular disease; Lipid profiles; Sedentary jobs

Indexed keywords

ANTIOXIDANT; CATALASE; CHOLESTEROL; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EMPLOYEE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INDIA; LIFESTYLE; LIPID PEROXIDATION; MALE; NORMAL HUMAN; OFFICE WORKER; PRIORITY JOURNAL; RISK ASSESSMENT; SCAVENGING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032803748     PISSN: 09627480     EISSN: None     Source Type: Journal    
DOI: 10.1093/occmed/49.5.313     Document Type: Article

References (50)

1. Wielgosz AT. The decline in cardiovascular health in developing countries. World Health Stat Q 1993; 46: 90-150.
2. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596-601.
3. Gupta R, Gupta VP. Meta-analysis of coronary heart disease prevalence in India. Ind Heart J 1996; 48: 241-245.
4. Halliwel B, Gutteridge JMC, eds. Free Radicals in Biology and Medicine. Oxford, UK: Claredon Press, 1989: 245-257.
5. Stocker R, Frei B. Endogenus antioxidant defences in human blood plasma. In: Sies H, ed. Oxidative Stress; Oxidant and Antioxidants. London, UK: Academic Press, 1991: 213-243.
6. Silagy C, Mant D. Antioxidant. In: Lawrence M, Neil A, Fowler G, Mant D, eds. Prevention of Cardiovascular Disease - An Evidence Based Approach. Oxford, UK: Oxford University Press, 1996: 154-163.
7. Reddy CD, Venkaiah B. Purification and characterization of Cu-zn Superoxide dismutase from mungbean (vigne radiata) seedlings. J Biosci 1984; 6: 115-123.
8. Fridovich I, Pryer WA, eds. Free Radicals in Biology. New York, NY (USA): Academic Press; 1976: 239.
9. Cotgreave IA, Moldeus P, Orrenius S. Host biochemical defence against peroxidants. Annal Rev Pharmcol Toxicol 1988; 28: 189-212.
10. Di Mascio P, Murphy ME, Sies H. Antioxidant defence system: the role of carotenoids, tocopherols and thiols. Am J Clim Nutn 1991; 53: 194S-200S
11. Burton GW, Ingold KV. Carotene: an unusual type of lipid antioxidant. Science 1984; 224: 569-573.
12. Burton GW, Joyce A, Ingold KV. Is vitamin E the only lipid soluble chin breaking antioxidant in human blood plasma and erythrocyte membrane? Arch Biochem Biophys 1983; 221: 281-290.
13. Frei B. Ascorbic acid protects lipids in human blood plasma and low density lipoprotein against oxidative damage. Am J Clin Nutr 1991; 54: 1113S-1118S.
14. Gey KF. Prospects for the prevention of free radical disease regarding cancer and cardiovascular disease. Br Med Bull 1993; 49: 679-699.
15. Mcintosh HD. Risk factors for cardiovascular disease and death, a clinical perspective. J Am Coll Cardiol 1989; 14: 24-30.
16. Obernan A. Exercise and primary prevention of cardiovascular disease. Am J Cardiol 1985; 55: 10D-20D.
17. Athavale AV, Durge PM, Zodpey SP, Deshpande SH. Prevalence and risk factors of coronary heart disease in sedentary workers. Ind J Indus Med 1997; 43: 10-14.
18. Siscovick DS, Laporate RE, Newman JM. The disease specific benefits and risk of physical activity and exercise. Public Health Rep 1985; 100: 18-188.
19. Waller B, Palumbo P, Lie J, Roberts W. Status of the coronary arteries at necropsy in diabetes mellitus with on set after age 30 years: analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 1980; 69: 498-506.
20. Vigorita V, Moore G, Hutchins G. Absence of correlation between coronary arterial atherosclerosis and severity or duration of diabetes mellitus of adult onset. Am J Cardiol 1980; 46: 535-542.
21. Mann J. Dibetes. In: Lawrence M, Neil A, Fowler G, Mant D, eds. Prevention of Cardiovascular Disease. An Evidence Based Approach, Oxford, UK: Oxford University Press, 1996: 105-119.
22. McKeigne P, Shah B, Marmot M. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-386.
23. Martin JM, Halley SB, Browner WS, Kuller LH, Wentworth D. Serum Cholesterol, blood pressure and mortality: implications from a cohort of 361,662 men. Lancet 1986; 11: 933-936.
24. Kannel WB. High density lipoproteins, epidemiologic profile and risks of coronary artery disease. Am J Cardiol 1993; 52: 9B-12B.
25. Pocock SJ, Shaper AG, Phillips AN. Concentration of high density lipoprotein, cholesterol, triglyceride and total cholesterol in ischaemic heart disease. Br Med J 1989; 298: 998-1002.
26. Gorden T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease: The Framinghan study. Am J Med 1977; 62: 707-714.
27. Leon AS, Conrad J, Hunninghake DB, et al. Effects cf vigorous walking programme on body composition and carbohydrate & lipid metabolism of obese young man. Am J Clin Nutr 1979; 32: 1776-1787.
28. Garrison RJ, Kannel WB, Feinleib M, et al. Cigarette smoking and HDL cholesterol. Atherosclerosis 1978; 30: 17-25.
29. Criqui MH, Wallace RB, Heiss G, et al. Cigarette smoking and plasma high density lipoprotein cholesterol. Circulation 1989; 62: 70-76.
30. Steinberg D. Antioxidants in the prevention of human atherosclerosis. Circulation 1992; 85: 2338-2344.
31. Austin MA. Plasma triglycerids as a risk factors for coronary heart disease. Am J Epidemiol 1989; 129: 249-259.
32. World Health Organisation. 'Arterial Hypertension' Tech. Report Series. 1978: 628.
33. Beutler E, Duron O, Kelly BM. Improve method for the determination of blood glutathione. J Lab Clin Med 1963; 61: 882-888.
34. Paglia WN, Valentine J. Studies on the quantitive and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70-: 158-169.
35. McKenna R, Ahmad T, Tsao C, Frisher H. Glutathione reductase deficiency and platelet disfunction induced by 1,3-bis (2 chloroethyl)-1-nitrosourea. J Lab Clin Med 1983; 102: 102-115.
36. Löhr GW, Waller HD. Glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. New York, NY (USA): Academic Press, 1974: 636-643.
37. Paoletti F, Aldinucci D, Mocali A, Caparrini L. A sensitive spectrophotemetric method for the determination of Superoxide dismutase activity in tissue extracts. Anal Biochem 1986; 154: 539-541.
38. Cohen G, Dembiec D, Marcus J. Measurement of catalase activity in tissue extracts. Annal Biochem 1970; 34: 30-38.
39. Levander OA, Deloach DP, Morris VC, Moser PB. Platlet glutathione peroxidase activity as an index of selenium status in rats. J Nutr 1983; 113: 55-63.
40. Takayama H, Okuma M, Uchino H. A simple method for estimation of lypoxygenase and cyclo oxygenase pathway in human platlets - The use of thiobarbituric acid reaction. Thromb Haemost 1980; 44: 111-114.
41. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total cholesterol. Clin Chem 1974; 470-475.
42. Varley H, Gowenlock AH, Bell M, eds. Practical Clinical Biochemistry. Vol. I. London, UK: William Heinemann Medical Books Ltd, 1980: 661-667.
43. Varley H, Gowenlock AH, Bell M, eds. Practical Clinical Biochemistry. Vol. I. London, UK: William Heineman Medical Books Ltd, 1980; 388-389
44. Lowry O, Rosenbrough NJ, Farr AL, Randall RJ. Protein measured with Folin Phenol Reagent. J Biol Chem 1951; 193: 265.
45. World Health Organization. Cardiovascular Disease Risk Factors. New Areas for Research. Technical Report Series. 1994; 9: 841.
46. Berenson GS, Srinivasan SR, Bao W, et al. For the Bogalusa Heart Study Association between multiple cardiovascular risk factors and atheroscleroies in children and young adults. N Engl Med 1998; 338: 1650-1656.
47. Mahoney LT, Lauer RM. Preventive cardiology across the life span: Paediatric issues: In: Pearson TA, Criqui MH, Luepker RV, Oberman A, Winston M, ed. Primer in Preventive Cardiology American Heart Association 1994: 255-260.
48. Pathobiological Determinants of Atherosclerosis in youth (PDAY) Research Group. Relationship of otherosclerosis in young men to serum lipoprotein cholesterol concentrations and Smoking: A preliminary report. JAMA 1990; 246: 3018-3024.
49. World Health Organisation. Prevention of Coronary Heart Disease; Tech. Report Series. 1982: 678.
50. Neil A. Lipids and lipoproteins. In: Lawrence M, Neil A, Fowler G, Mant D, eds. Prevention of Cardiovascular Disease - An Evidence Based Approach. Oxford, UK: Oxford University Press, 1996: 35-53.